Company ALPHANCO VEN

Marvel Biosciences Corp, formerly Alphanco Venture Corp, is a Canada-based life sciences company. The Company is focused on discovery and the development of pharmaceutical products for the treatment of neurologically associated diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder ADHD, and addiction), cancer, and application to the non-neurological disease of non-alcoholic steatohepatitis liver fibrosis. The Company also intends to advance compound 1b (MB-204) into Phase 1 clinical trials for neurological diseases.